糖尿病、肥胖与心血管疾病表型之间的关系:一项英国生物银行队列研究
研究基于英国生物银行451,355名参与者,按族裔特异性BMI分类和糖尿病状态分层,分析心血管生物标志物及心肌梗死、缺血性卒中、心血管死亡发生率。结果显示肥胖与糖尿病对心血管生物标志物和死亡风险呈相加关联,正常体重糖尿病的心血管死亡风险与肥胖非糖尿病相当。
要点
- 5%参与者有糖尿病,其中正常体重、超重、肥胖分别占10%、34%、55%。
- 非糖尿病人群中,超重/肥胖与更差心血管生物标志物相关(P < 0.005)。
- 随访5,323,190人年后,非糖尿病人群心血管事件随BMI升高而增加(P < 0.005)。
核心结论
- 肥胖和糖尿病与不良心血管生物标志物及死亡风险呈相加关联。
- 脂肪指标与心血管生物标志物的相关性比糖尿病相关指标更强,但两者相关性均较弱,提示正常体重糖尿病的高心血管风险可能由其他因素支撑。
研究设计与样本
- 英国生物银行队列研究,共纳入451,355名参与者。
- 按族裔特异性BMI分类(正常、超重、肥胖)和糖尿病状态分层。
- 检测心血管生物标志物包括颈动脉内中膜厚度(CIMT)、动脉硬度、左心室射血分数(LVEF)和心脏收缩力指数(CCI)。
- 采用泊松回归模型估计心肌梗死、缺血性卒中和心血管死亡的调整发病率比(IRR),以正常体重非糖尿病者为对照。
主要发现
- 5%参与者有糖尿病,其中正常体重、超重、肥胖分别占10%、34%、55%,非糖尿病人群中分别占34%、43%、23%。
- 非糖尿病人群中,超重/肥胖与更高的CIMT、动脉硬度和CCI以及更低的LVEF相关(P < 0.005);这些关系在糖尿病人群中减弱。
- 在BMI分类内,糖尿病与不良心血管生物标志物表型相关(P < 0.005),尤其在正常体重组。
- 随访5,323,190人年后,非糖尿病人群中心肌梗死、缺血性卒中和心血管死亡率随BMI分类升高而增加(P < 0.005);糖尿病人群中趋势相似(交互P > 0.05)。
- 正常体重糖尿病者的调整心血管死亡率与肥胖非糖尿病者相当(IRR 1.22 [95% CI 0.96-1.56];P = 0.1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Obesity and diabetes frequently coexist, yet their individual contributions to cardiovascular risk remain debated. We explored cardiovascular disease biomarkers, events, and mortality in the UK Biobank stratified by BMI and diabetes. RESEARCH DESIGN AND METHODS: A total of 451,355 participants were stratified by ethnicity-specific BMI categories (normal, overweight, obese) and diabetes status. We examined cardiovascular biomarkers including carotid intima-media thickness (CIMT), arterial stiffness, left ventricular ejection fraction (LVEF), and cardiac contractility index (CCI). Poisson regression models estimated adjusted incidence rate ratios (IRRs) for myocardial infarction, ischemic stroke, and cardiovascular death, with normal-weight nondiabetes as comparator. RESULTS: Five percent of participants had diabetes (10% normal weight, 34% overweight, and 55% obese vs. 34%, 43%, and 23%, respectively, without diabetes). In the nondiabetes group, overweight/obesity was associated with higher CIMT, arterial stiffness, and CCI and lower LVEF (P < 0.005); these relationships were diminished in the diabetes group. Within BMI classes, diabetes was associated with adverse cardiovascular biomarker phenotype (P < 0.005), particularly in the normal-weight group. After 5,323,190 person-years follow-up, incident myocardial infarction, ischemic stroke, and cardiovascular mortality rose across increasing BMI categories without diabetes (P < 0.005); this was comparable in the diabetes groups (P-interaction > 0.05). Normal-weight diabetes had comparable adjusted cardiovascular mortality to obese nondiabetes (IRR 1.22 [95% CI 0.96-1.56]; P = 0.1). CONCLUSIONS: Obesity and diabetes are additively associated with adverse cardiovascular biomarkers and mortality risk. While adiposity metrics are more strongly correlated with cardiovascular biomarkers than diabetes-oriented metrics, both correlate weakly, suggesting that other factors underpin the high cardiovascular risk of normal-weight diabetes.
引用
- Brown OI, Drozd M, McGowan H, et al. Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study. Diabetes Care. 2023. PMID: 37368983. doi:10.2337/dc23-0294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。